Clinical Lung Cancer

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical Lung Cancer is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,110 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1525-7304 · 1938-0690
Country
United States
Access
Not open access / not declared
Declared publication charge
3,110 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2003-01-01
Indexing
MEDLINE
APC
3,110 USD
Declared review time (DOAJ)
—
Actual review time (measured)
110 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3199

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

92

i10-index

1578

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
71%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
100893225
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
Show all subjects (50)
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Brain Metastases and Treatment
  • Brain Metastases and Treatment
  • Pleural and Pulmonary Diseases
  • Pleural and Pulmonary Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Occupational and environmental lung diseases
  • Occupational and environmental lung diseases
  • Ferroelectric and Negative Capacitance Devices
  • Big Data and Digital Economy
  • Big Data and Digital Economy
  • Ferroelectric and Negative Capacitance Devices
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • PI3K/AKT/mTOR signaling in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Effects of Radiation Exposure
  • Effects of Radiation Exposure
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: